PPH
VanEck Pharmaceutical ETF
stockNASDAQETF
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 111.48 | 2026-09-28 | -3.03% | 0.858 |
| 1M | 114.21 | 2026-09-04 | -5.35% | 0.589 |
| 3M | 109.96 | 2026-07-06 | -1.69% | -0.084 |
| 6M | 103.30 | 2026-04-06 | +4.65% | 0.028 |
| 1Y | 93.72 | 2025-10-06 | +15.34% | 0.272 |
| 2Y | 93.41 | 2024-10-04 | +15.73% | — |
| 5Y | 72.56 | 2021-10-05 | +48.98% | 0.452 |
VanEck Pharmaceutical ETF (NASDAQ:PPH) stock price today is $108.10, and today's volume is 272,521. PPH is down 0.037% today. The 30 day average volume is 275,804. PPH market cap is $993.24M with 9.19M shares outstanding.